Kynos Therapeutics

Description: Kynos Therapeutics develops KMO-targeting drugs to treat inflammation-driven conditions like critical illness, endometriosis, and immune-evading cancers.

Country: UK

Based in: Edinburgh

Founded: 2020

Funding Stage: Seed

Tags: ['Biotechnology', 'Health Care', 'Medical', 'Therapeutics']

Categories

Add insights to your inbox

We’ll send you content you’ll want to read- and put to use.

Details about how we process your information are available in our Privacy Policy.